183 related articles for article (PubMed ID: 12361885)
1. Bisphosphonates.
Diez-Perez A
Maturitas; 2002 Aug; 43 Suppl 1():S19-26. PubMed ID: 12361885
[No Abstract] [Full Text] [Related]
2. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Trémollières F
Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
[No Abstract] [Full Text] [Related]
3. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
4. Role of alendronate and risedronate in preventing and treating osteoporosis.
Peters ML; Leonard M; Licata AA
Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
[TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
6. Risedronate: a new oral bisphosphonate.
Umland EM; Boyce EG
Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
[TBL] [Abstract][Full Text] [Related]
7. Gastroenterologists and choosing the right bisphosphonate.
Leder BZ; Kronenberg HM
Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
[No Abstract] [Full Text] [Related]
8. Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Rackoff PJ; Sebba A
Treat Endocrinol; 2005; 4(4):245-51. PubMed ID: 16053341
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates.
Lambrinoudaki I; Christodoulakos G; Botsis D
Ann N Y Acad Sci; 2006 Dec; 1092():397-402. PubMed ID: 17308164
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for osteoporosis.
Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
[TBL] [Abstract][Full Text] [Related]
11. Differences in persistence among different weekly oral bisphosphonate medications.
Sheehy O; Kindundu CM; Barbeau M; LeLorier J
Osteoporos Int; 2009 Aug; 20(8):1369-76. PubMed ID: 19020921
[TBL] [Abstract][Full Text] [Related]
12. Use of highly potent bisphosphonates in the treatment of osteoporosis.
McClung M
Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074
[TBL] [Abstract][Full Text] [Related]
13. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
14. Once-a-week risedronate (actonel).
Med Lett Drugs Ther; 2002 Oct; 44(1141):87-8. PubMed ID: 12381968
[No Abstract] [Full Text] [Related]
15. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
16. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
17. Long-term experience with alendronate in the treatment of osteoporosis.
Hochberg MC; Rizzoli R
Expert Opin Pharmacother; 2006 Jun; 7(9):1201-10. PubMed ID: 16732706
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
Papapoulos SE
Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
[No Abstract] [Full Text] [Related]
19. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
Cramer JA; Amonkar MM; Hebborn A; Altman R
Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Chapurlat RD
Treat Endocrinol; 2005; 4(2):115-25. PubMed ID: 15783248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
